top of page

Search

How Is the Treatment of Patients with KRAS G12C-Mutated Advanced NSCLC Evolving? Learn more! 4/11/23

Mar 24, 2023
0 min read

Recent Posts

NEW EVENT! An Approved Trop2-Directed ADC forAdults With Previously Treated HR+/HER2–(IHC 0, IHC 1+ or IHC 2+/ISH–) MetastaticBreast Cancer - May 13th!

NEW EVENT! An Approved Trop2-Directed ADC forAdults With Previously Treated HR+/HER2–(IHC 0, IHC 1+ or IHC 2+/ISH–) MetastaticBreast Cancer - May 13th!

New Event! Program on ZEPZELCA

New Event! Program on ZEPZELCA

New Event! RYBREVANT FASPRO + LAZCLUZE for EGDR + Locally Advanced or Metastatic NSLC

New Event! RYBREVANT FASPRO + LAZCLUZE for EGDR + Locally Advanced or Metastatic NSLC

Comments

bottom of page